DE602006016441D1 - Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss - Google Patents

Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss

Info

Publication number
DE602006016441D1
DE602006016441D1 DE602006016441T DE602006016441T DE602006016441D1 DE 602006016441 D1 DE602006016441 D1 DE 602006016441D1 DE 602006016441 T DE602006016441 T DE 602006016441T DE 602006016441 T DE602006016441 T DE 602006016441T DE 602006016441 D1 DE602006016441 D1 DE 602006016441D1
Authority
DE
Germany
Prior art keywords
material flow
disposal system
barrier against
reservoir material
multilayer drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006016441T
Other languages
English (en)
Inventor
Rolf R Jansen
Dina J Coronado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE602006016441D1 publication Critical patent/DE602006016441D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A61F13/0203—Adhesive plasters or dressings having a fluid handling member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10—Methods of surface bonding and/or assembly therefor
    • Y10T156/1052—Methods of surface bonding and/or assembly therefor with cutting, punching, tearing or severing
    • Y10T156/1082—Partial cutting bonded sandwich [e.g., grooving or incising]
DE602006016441T 2005-05-13 2006-05-12 Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss Active DE602006016441D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68090505P 2005-05-13 2005-05-13
US79023606P 2006-04-07 2006-04-07
PCT/US2006/018426 WO2006124584A2 (en) 2005-05-13 2006-05-12 Multilayer drug delivery system with barrier against reservoir material flow

Publications (1)

Publication Number Publication Date
DE602006016441D1 true DE602006016441D1 (de) 2010-10-07

Family

ID=36928681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006016441T Active DE602006016441D1 (de) 2005-05-13 2006-05-12 Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss

Country Status (10)

Country Link
US (3) US20060257461A1 (de)
EP (3) EP1895994B1 (de)
AT (1) ATE478659T1 (de)
CY (1) CY1111436T1 (de)
DE (1) DE602006016441D1 (de)
DK (1) DK1895994T3 (de)
HK (1) HK1157244A1 (de)
PL (1) PL1895994T3 (de)
PT (1) PT1895994E (de)
WO (2) WO2006124585A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006016441D1 (de) * 2005-05-13 2010-10-07 Alza Corp Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss
WO2007035939A2 (en) * 2005-09-23 2007-03-29 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
EP1937226A2 (de) * 2005-09-23 2008-07-02 Alza Corporation Transdermales galantaminzufuhrsystem
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
CN105534936B (zh) * 2007-08-13 2020-07-31 Ohemo 生命科学股份有限公司 抗滥用药物、使用方法和制备方法
AU2009302853B2 (en) * 2008-10-06 2014-09-11 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
KR101317158B1 (ko) * 2011-02-18 2013-10-15 조선대학교산학협력단 갈란타민 또는 그의 염을 함유하는 경피흡수제제
KR101840526B1 (ko) 2013-02-05 2018-03-20 퍼듀 퍼머 엘피 내변조성 제약 제제
WO2015021031A1 (en) 2013-08-05 2015-02-12 Cam Med Llc Conformable patch pump
KR101485822B1 (ko) * 2014-01-22 2015-01-23 주식회사 대웅제약 도네페질 또는 그의 염을 함유하는 경피흡수제제
US10449201B2 (en) * 2015-08-17 2019-10-22 Alpha To Omega Pharmaceutical Consultants, Inc. Transdermal and/or topical delivery system comprising clobazam
DE102018216244A1 (de) * 2018-09-24 2020-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Barriereschicht
ES2936735B2 (es) * 2021-09-20 2023-11-29 Paterna Jesus Paterna Dispositivo para preparar manualmente sistemas terapéuticos transdérmicos y procedimiento

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493657A (en) * 1961-03-14 1970-02-03 Mozes Juda Lewenstein Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3773955A (en) * 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions
GB1451994A (en) * 1973-07-20 1976-10-06 Smithe Machine Co Inc F L Method and apparatus for cutting and applying patches
US4214557A (en) * 1978-08-15 1980-07-29 Beach Corbett D Jr Pivoting wall type, four stroke, internal combustion, rotary engine
US4457933A (en) * 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4314557A (en) 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
GB8728294D0 (en) * 1987-12-03 1988-01-06 Reckitt & Colmann Prod Ltd Treatment compositions
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
DE4010079A1 (de) * 1990-03-29 1991-10-02 Lohmann Therapie Syst Lts Pharmazeutische formulierung zur behandlung des alkoholismus
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
WO1993023025A1 (en) * 1992-05-13 1993-11-25 Alza Corporation Transdermal administration of oxybutynin
DE4301783C1 (de) 1993-01-23 1994-02-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil
US6316439B1 (en) * 1993-10-15 2001-11-13 Aventis Pharamaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323196B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
CA2215518C (en) * 1995-04-06 2006-11-28 Chiroscience Limited Process for preparing galanthamine derivatives by asymmetric reduction
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
GB9514821D0 (en) * 1995-07-19 1995-09-20 Sod Conseils Rech Applic Galanthamine derivatives
GB9519268D0 (en) * 1995-09-21 1995-11-22 Chiroscience Ltd Preparation of alkaloids
GB9519267D0 (en) * 1995-09-21 1995-11-22 Chiroscience Ltd Preparation of alkaloids
EP0934078B1 (de) * 1996-10-24 2002-12-18 Alza Corporation Penetrationsfördernde substanzen für die transdermale verabreichung von wirkstoffen, vorrichtungen und verfahren zur herstellung
JP2003522144A (ja) 2000-02-08 2003-07-22 ユーロ−セルティーク，エス．エイ． オピオイドアゴニストおよびアンタゴニストを含む制御放出組成物
RU2708563C2 (ru) 2001-03-16 2019-12-10 Алза Корпорейшн Трансдермальный пластырь для введения фентанила
ATE533478T1 (de) 2001-05-01 2011-12-15 Euro Celtique Sa Missbrauchssichere opioide mit transdermalen systemen
FR2826005B1 (fr) * 2001-06-15 2004-07-16 Centre Nat Rech Scient Synthese totale de la galanthamine, de ses analogues et de ses derives
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
KR20050050615A (ko) 2002-04-23 2005-05-31 알자 코포레이션 남용될 가능성이 감소된 경피용 진통제 시스템
US8524272B2 (en) * 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
EP1898891A2 (de) * 2005-05-13 2008-03-19 Alza Corporation System zur verabreichung mehrschichtiger arzneimittel mit sperre gegen antagonisten
DE602006016441D1 (de) * 2005-05-13 2010-10-07 Alza Corp Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss

Also Published As

Publication number Publication date
US20140130973A1 (en) 2014-05-15
EP2316437A1 (de) 2011-05-04
PT1895994E (pt) 2010-12-03
US8632800B2 (en) 2014-01-21
WO2006124584A2 (en) 2006-11-23
EP2316437B1 (de) 2014-07-30
WO2006124584A3 (en) 2007-04-19
ATE478659T1 (de) 2010-09-15
PL1895994T3 (pl) 2011-02-28
DK1895994T3 (da) 2010-12-20
EP1895994A2 (de) 2008-03-12
US20060257461A1 (en) 2006-11-16
US20060257462A1 (en) 2006-11-16
CY1111436T1 (el) 2015-08-05
WO2006124585A3 (en) 2007-05-03
EP1895995A2 (de) 2008-03-12
EP1895994B1 (de) 2010-08-25
HK1157244A1 (en) 2012-06-29
WO2006124585A2 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
DE602006016441D1 (de) Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss
WO2006124749A3 (en) Multilayer drug delivery system with barrier against antagonist exposure
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
SMAP200900075A (it) Dispositivi terapeutici ibridi impiantabili
ES2571854T3 (es) Dispositivo de suministro montable en superficie
BRPI0514834B8 (pt) processo de montagem de dispositivos de envio de fármaco e dispositivo de envio de fármaco
CO6251228A2 (es) Articulo absorbente con lamina de superficie irregular compuesta por secciones concavas y convexas y un cuerpo absorbente con una seccion entremezclada densamente recogida
DK1601396T4 (da) Forbedringer i drivmekanismer egnet til anvendelse i lægemiddelafgivelsesindretninger
WO2009045784A3 (en) Disposable infusion device layered structure
DE602005027059D1 (de) Polymer-füllstoff-komposite für die kontrollierte abgabe von therapeutischen mitteln aus medizinischen artikeln
HK1184701A1 (en) Use of glycosaminoglycan containing a binded hydrophobic group in the preparation of medicine for treating or preventing corneal epithelial layer disorders
CL2008000461A1 (es) Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos.
AR040053A1 (es) Un articulo absorbente descartable
HK1142270A1 (en) Silibinin component for the treatment of hepatitis
ECSP099629A (es) Composición farmacéutica
AR058849A1 (es) Producto absorbente y procedimiento para fabricar productos absorbentes
ATE477774T1 (de) Verabreichungskatheter mit einem transplantat- injektionsmechanismus
CL2014001478A1 (es) Pelicula de capas multiples libre de capa metalica, que comprende una capa exterior de al menos un polimero de olefina termoplastica, capa de agente de adherencia, capa de al menos una poliamida, capa de barrera de gas, capa de poliamida, adyacente a la anterior, y capa exterior de poliamida; uso; cuerpo ascencional; y globo.
FR2934773B1 (fr) Lit de malade a barriere laterale facilitant la levee du patient.
DE502004011970D1 (de) Strömungsarbeitsmaschine mit Fluidzufuhr zur Grenzschichtbeeinflussung
AR061634A1 (es) Material compuesto de madera que contiene paulonia
ATE505323T1 (de) Behälter für medizinische flüssigkeiten mit hoher wasserdampfsperre
ES2422286T3 (es) Uso de apamina para tratar la enfermedad de Parkinson
JP2009509116A5 (de)
BR112014002414A2 (pt) equipamento de sinalização de resfriamento para uso em artigo absorvente